Olio and AION Biosystems Integrate Wearables for Post-Discharge Monitoring
Event summary
- Olio partners with AION Biosystems to integrate TempShield wearables into post-discharge care coordination.
- TempShield monitors body temperature continuously for up to 90 days, feeding data into Olio’s Safe Return workflows.
- Pilot with Trilogy Health Services showed a 67% hospital prevention rate among monitored residents.
- Partnership aims to reduce avoidable readmissions and improve infection detection in post-acute care transitions.
The big picture
The partnership addresses a critical gap in post-discharge monitoring, where continuous clinical oversight often ends when patients leave skilled nursing facilities (SNFs). With sepsis mortality increasing by 7.6% per hour of delayed treatment and SNF residents being 7x more likely to develop severe sepsis, this integration could reshape how care transitions are managed in value-based healthcare models.
What we're watching
- Adoption Pace
- How quickly the partnership scales across Olio’s 15,000+ SNF network and whether it drives measurable reductions in readmissions.
- Regulatory Dynamics
- Whether FDA-cleared wearables like TempShield gain broader acceptance in value-based care models.
- Competitive Response
- How competitors in post-acute care coordination react to this data-driven intervention strategy.
Related topics